FNY Investment Advisers’s OKYO Pharma OKYO Stock Holding History

FNY Investment Advisers’s Portfolio OKYO Stock Details OKYO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-20,000	Closed	-$25K	–	1121
2025 Q1	$25K	Buy	+20,000	New	+$23.9K	0.02%	369

Other funds holding OKYO

DIG

Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return

Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

FNY Investment Advisers's OKYO Position: Q2 2025 in Review

FNY Investment Advisers sold out of OKYO Pharma (OKYO) in Q2 2025, closing a stake of 20,000 shares — an estimated $25K sold.

FNY Investment Advisers first reported a position in OKYO in Q1 2025 and held it in 1 quarter. The position peaked at $25K in Q1 2025. 5 funds tracked by Wall St. Rank hold OKYO as of Q2 2025.

FNY Investment Advisers reported no remaining OKYO Pharma position as of Q2 2025 after selling out during the quarter.
FNY Investment Advisers sold 20,000 OKYO Pharma shares in Q2 2025, an estimated $25K.
FNY Investment Advisers first reported a position in OKYO Pharma in Q1 2025 and held it in 1 quarter.
FNY Investment Advisers's OKYO Pharma position peaked at $25K in Q1 2025.
5 funds tracked by Wall St. Rank held OKYO Pharma as of Q2 2025.

Based on FNY Investment Advisers's 13F filing for Q2 2025, filed 30 Jul 2025.